To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

May 17, 2023

Imvax Immunotherapy Clinical Study


We wanted to make you aware of a new Phase 2b Clinical Study with a Combination Immunotherapy for Newly Diagnosed Patients with Glioblastoma (GBM).

Imvax is a clinical-stage biotechnology company with a unique platform technology, Goldspire™, focused on delivering personalized, whole tumor-derived immunotherapies across a range of solid tumors. Imvax’s most advanced program, IGV-001, is currently being evaluated in a Phase 2b clinical trial in newly diagnosed glioblastoma patients (NCT04485949). Imvax’s portfolio also includes several other programs designed to stimulate a patient’s immune system against the entire antigen signature of their tumor. Imvax is headquartered in Philadelphia, PA.

For additional information on the Imvax Immunotherapy Clinical Study, please visit and follow @imvax_inc on Twitter and LinkedIn, contact Madhavi Diwanji at 267-900-4110 or at  OR please contact, fill out our short “Advocacy & Patient Inquiry Form” on our website, or call EBCI’s Program & Trial/Study Manager at 425-436-8688 or email us at  We are here to help.


Dellann Elliott Mydland
President & Board Chair

The EndBrainCancer Initiative | Chris Elliott Fund


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram